San Marino, Calif., Jun 20, 2012 – Viral Genetics, through its majority owned subsidiary VG Energy, is now verifying the chemical activity in industrial scale batches of LipidMax™ in response to demand for the product from research institutes and from industry.
Vienna, June 19, 2012 /PRNewswire/ — SEE ALGAE Technology GmbH , a developer of infrastructure for the commercial production of high-quality algae, announced today that it had signed an agreement to supply and install a 1 hectare „dual-use“ algae production plant for Recife, Brazil-based Grupo JB one of the leading bioethanol producers in Brazil.
A new announcement of the Department of Energy has been released concerning a funding opportunity for advanced biofuels focusing on military and aviation use. About $40 million are going to be spent along 2012/2013 on lignocellulosic and algal biofuel production plants.
San Marino, CA (PRWEB) June 15, 2012 – VG Energy, the majority-owned subsidiary of Viral Genetics, has entered into an agreement with UniQuest Pty. Ltd., the commercialization arm of the University of Queensland, Australia, to optimize the use of Metabolic Disruption Technology (“MDT”) compounds in algae lipid production.
In Zusammenarbeit mit der GMB GmbH, einem Tochterunternehmen der Vattenfall Europe Mining AG, hat das Berliner Biotechnologie Unternehmen FIM Biotech GmbH (FIM) ein kostengünstiges und effizientes Verfahren entwickelt, durch den Einsatz von CO2 -haltigen Abgasen aus konventionellen Kraftwerken eine proteinreiche Biomasse herzustellen, die als Futtermittelstoff geeignet ist.
WATSONVILLE, Calif., June 2012 – Nordic Naturals, manufacturer of omega-3 supplements, has introduced Algae Omega™, a solution for vegetarians seeking the health benefits of marine omega-3s. Made from sustainably sourced microalgae and available in both soft gels and liquid, the product offers an algae-based source of beneficial marine omega-3 essential fatty acids without the use of fish.
San Diego, CA – Sapphire Energy, Inc. today welcomed new members to its Scientific Advisory Board as the company readies its first algae-to-energy commercial demonstration facility. The new board members represent some of the most innovative academics across key scientific and engineering disciplines, including chemistry, molecular biology, plant biology, biotechnology, and chemical engineering.
Galactic is to be actively involved in the ECLIPSE project launched by the European Community as part of the 7th Framework Programme. The aim of this project is to use microalgae ‚waste‘ from the biodiesel process as a raw material for producing lactic acid by fermentation, which in turn will be used to produce PLA (polylactic acid). The project was chosen over several others because of its scientific excellence. At an estimated cost of 5 million EUR it will bring together 13 industrial players and research centres.
SAN DIEGO, CA AND KAILUA-KONA, HI – Cellana, Inc. announced the launch of its ReNew™ brand and ReNew™ Omega-3 line of algae-based products at the GOED (Global Organization for EPA and DHA) conference being held this week in Boston, Massachusetts. The ReNew™ brand was developed to meet the growing demand for more sustainable Omega-3 human health products, animal nutrition products, and biofuel feedstocks.
A sound strategy for marine biotechnology research, technology development and innovation and a concerted coordination of relevant national and regional programmes are urgently needed in Europe. Funded by the European Commission’s Seventh Framework Programme as a Coordination and Support Action ‘MarineBiotech’ CSA MarineBiotech is a response to this, aiming at an ERA-NET in marine biotechnology that can deliver ‘smart, sustainable and inclusive growth’, a core objective of the Europe 2020 Strategy.